Avalon Pharmaceuticals Inc.

Novartis: - A Detailed And Comprehensive Overview Of Current Financial Position, Company Strategy, Product And Pipeline Analysis.
M2 Presswire; 12/3/2009; 1396 words; ...per cent. Within Pharmaceuticals, Novartis' strategic...Novartis has a strong pharmaceutical pipeline with a total...same price. This pharmaceutical company intelligence...Allergan - Alnylam Pharmaceuticals - Anadys Pharmaceuticals Inc - Antisoma plc...Pharmaceuticals ...

Clinical Data, Inc. Reports Second Quarter Fiscal 2010 Results.(Company overview)(Financial report)
Blood Weekly; 11/26/2009; 2052 words; Clinical Data, Inc. (NASDAQ: CLDA...Directors to include pharmaceutical industry leader, Scott...core assets from the Avalon Pharmaceuticals acquisition for $1...also Clinical Data, Inc.). For the three...core assets from the Avalon acquisition, which...

Distracted by merger, Pfizer waffles on future of La Jolla incubator; what's next for incubating firms?(LIFE SCIENCES)
San Diego Business Journal; 11/23/2009; 1165 words; ...years ago, Pfizer Inc. dedicated a building...technologies. The pharmaceutical giant committed to...operations with Wyeth Pharmaceuticals. "Right now, it...she said. But the pharmaceutical giant, which pledged...Cushman & Wakefield Inc. broker Steve Rosetta...funded, according to ...

BioVex's $70M Series F to Fund Pivotal OncoVex Melanoma Trial.
BIOWORLD Today; 11/11/2009; 1431 words; ...of that stopped BioVex Inc. from raising $70 million...GeneChem Management, Avalon Ventures and Forbion...failures have included Genta Inc.'s Genasense (oblimersen sodium), Synta Pharmaceuticals Corp.'s elesclomol, Onyx Pharmaceuticals Inc. and Bayer AG's Nexavar...

Clinical Data, Inc. Reports Second Quarter Fiscal 2010 Results.
Business Wire; 11/9/2009; 2330 words; ...Clinical Data, Inc. (NASDAQ: CLDA...Directors to include pharmaceutical industry leader, Scott...core assets from the Avalon Pharmaceuticals acquisition for $1...core assets from the Avalon acquisition, which...future cost savings in Avalon research and development...